脂肪细胞来源脂质通过FATP蛋白介导黑色素瘤进展
晚期黑色素瘤常生长于富含脂肪细胞的皮下组织。研究利用体外和体内模型发现,脂肪细胞直接向黑色素瘤细胞转移脂质,改变肿瘤代谢并促进增殖和侵袭。脂质转移依赖肿瘤细胞表面FATP/SLC27A家族转运蛋白,其中FATP1/SLC27A1在黑色素瘤中显著过表达。在斑马鱼和小鼠模型中,FATP1与BRAFV600E协同加速黑色素瘤发生。小分子抑制剂Lipofermata阻断FATP功能,减少脂质摄取并抑制肿瘤生长和侵袭。
要点
- 脂肪细胞通过FATP/SLC27A转运蛋白向黑色素瘤细胞转移脂质,促进肿瘤进展。
- FATP1/SLC27A1在黑色素瘤中显著过表达,与BRAFV600E协同加速肿瘤发生。
- FATP抑制剂Lipofermata可阻断脂质摄取,减少黑色素瘤生长和侵袭。
核心结论
- 基质脂肪细胞通过FATP脂质转运蛋白驱动黑色素瘤进展,是新的微环境治疗靶点。
研究设计与样本
- 研究采用体外和体内模型,包括转基因斑马鱼和小鼠异种移植模型。
主要发现
- 脂肪细胞增加邻近黑色素瘤细胞的增殖和侵袭,并直接转移脂质改变肿瘤细胞代谢。
- 脂肪细胞来源脂质通过肿瘤细胞表面的FATP/SLC27A家族转运蛋白进入黑色素瘤细胞。
- 在六个FATP/SLC27A家族成员中,黑色素瘤显著过表达FATP1/SLC27A1。
- 黑色素细胞特异性表达FATP1与BRAFV600E协同加速斑马鱼黑色素瘤发展,小鼠异种移植研究也观察到类似效应。
- 小分子抑制剂Lipofermata药理阻断FATPs,减少脂质转运进入黑色素瘤细胞,并降低黑色素瘤生长和侵袭。
临床怎么用
- 靶向FATP/SLC27A脂质转运蛋白可能阻断脂肪细胞与黑色素瘤细胞之间的交叉对话,抑制肿瘤进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Advanced, metastatic melanomas frequently grow in subcutaneous tissues and portend a poor prognosis. Though subcutaneous tissues are largely composed of adipocytes, the mechanisms by which adipocytes influence melanoma are poorly understood. Using in vitro and in vivo models, we find that adipocytes increase proliferation and invasion of adjacent melanoma cells. Additionally, adipocytes directly transfer lipids to melanoma cells, which alters tumor cell metabolism. Adipocyte-derived lipids are transferred to melanoma cells through the FATP/SLC27A family of lipid transporters expressed on the tumor cell surface. Among the six FATP/SLC27A family members, melanomas significantly overexpress FATP1/SLC27A1. Melanocyte-specific FATP1 expression cooperates with BRAFV600E in transgenic zebrafish to accelerate melanoma development, an effect that is similarly seen in mouse xenograft studies. Pharmacologic blockade of FATPs with the small-molecule inhibitor Lipofermata abrogates lipid transport into melanoma cells and reduces melanoma growth and invasion. These data demonstrate that stromal adipocytes can drive melanoma progression through FATP lipid transporters and represent a new target aimed at interrupting adipocyte-melanoma cross-talk.Significance: We demonstrate that stromal adipocytes are donors of lipids that mediate melanoma progression. Adipocyte-derived lipids are taken up by FATP proteins that are aberrantly expressed in melanoma. Inhibition of FATPs decreases melanoma lipid uptake, invasion, and growth. We provide a mechanism for how stromal adipocytes drive tumor progression and demonstrate a novel microenvironmental therapeutic target. Cancer Discov; 8(8); 1006-25. ©2018 AACR.This article is highlighted in the In This Issue feature, p. 899.
引用
- Zhang M, Di Martino JS, Bowman RL, et al. Adipocyte-Derived Lipids Mediate Melanoma Progression via FATP Proteins. Cancer Discov. 2018. PMID: 29903879. doi:10.1158/2159-8290.CD-17-1371
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。